niftify.in

The Economic Times

Market Trading Guide: Century Textiles, Jubilant Foodworks among 5 stock recommendations for Friday

Equity indices hit record highs following the Fed's larger-than-expected 50 basis point interest rate cut and indications of possible further reductions. The significant rate cut raised concerns about a global slowdown, leading to profit-taking in mid and small-cap stocks that are trading at premium valuations.

CNBC TV18

Andhra's new liquor policy can boost volumes of alcoholic beverage players by 7-8%, says expert

Karan Taurani of Elara Capital, believes most companies are fairly priced, with many trading 10% to 12% above target prices, except for UBL, which still has room for performance improvement.

The Economic Times

Hemang Jani on 3 liquor stocks to bet on for long term

​So, on an overall basis, very positive outlook on the spirits companies per se. I think United Spirits, Radico Khaitan, United Breweries, all should be part of the long-term investment portfolio.

CNBC TV18

Analysts recommend buying Marico, Crompton, Tata Consumer, UBL and Shriram Finance for today's trade

On Tuesday, market tech analysts Apurva Sheth, Mitessh Thakkar and Shilpa Rout recommended these stocks for the short term.

Business Standard

Jhunjhunwala Portfolio: This pharma stock has zoomed over 100% in 6 months

Shares of Jubilant Pharmova surged 12 per cent on the BSE in Friday's intra-day trade to hit a new high of Rs 1,169.55, in an otherwise subdued market.

Business Standard

Jubilant Pharmova hits all time high on receiving 'VAI' tag for US facility

Jubilant Pharmova share price rose as much as 4.2 per cent, touching its all time high at Rs 1060.15 per share on the BSE in early hours of Wednesday's intraday deals

Business Standard

Jubilant Pharmova gains as Washington unit gets VAI classification from USFDA

Jubilant Pharmova advanced 1.60% to Rs 1,033.55 after its subsidiary, Jubilant HollisterStier LLC's (JHS) manufacturing facility located at Spokane, Washington (USA) received classification of "Voluntary Action Indicated" from USFDA.

Mint

Top Stock Recommendations: Aakash Hindocha of Nuvama suggests Jubilant FoodWorks, Aegis Logistics, and Tata Power today

Top Stock Recommendations: Aakash K Hindocha of Nuvama Professional Clients Group recommends these three stocks for today - Jubilant FoodWorks Ltd, Aegis Logistics Ltd, and Tata Power Company Ltd.

CNBC TV18

Jubilant Pharmova subsidiary gets US FDA note for Washington unit

Following an audit conducted from May 28-June 6, 2024, the US FDA has classified the drug firm's Spokane, Washington, manufacturing facility's inspection status as 'voluntary action indicated' (VAI). Shares of Jubilant Pharmova Ltd ended at ₹1,014.10, down by ₹16.30, or 1.58%, on the BSE.

The Economic Times

Technical Breakout Stocks: How to trade Hindustan Unilever, Jubilant Pharmova and Glenmark Life on Tuesday?

Indian markets ended higher on Monday, with the S&P BSE Sensex up over 370 points and Nifty50 maintaining 24,900 levels. Gains were seen in consumer durables, banks, and FMCG, while sectors like PSU and energy saw declines.

Business Standard

Jubilant Pharmova Ltd leads gainers in 'A' group

Morepen Laboratories Ltd, La Opala RG Ltd, AGI Greenpac Ltd and Gujarat Alkalies & Chemicals Ltd are among the other gainers in the BSE's 'A' group today, 09 September 2024.

The Economic Times

How will Biosecure Act impact Indian pharma companies? Aditya Khemka explains

​We own a stock here called Jubilant Pharmova. The company was given a grant from the US government to create a manufacturing facility on the US soil and the US government would have the right of first refusal on production on the facility. And when the US government does not want to source material from that facility, the company is free to manufacture other materials and sell it to whoever they wish to sell.

The Economic Times

Jubilant FoodWorks, Persistent Systems among 6 midcap stocks that hit new 52-week highs on Thursday

undefined

Mint

Some retail stocks are defying gravity. It’s best to avoid them.

The valuations of Trent, Jubilant Foodworks, and Avenue Supermarts in particular factor in an unrealistic pace of growth.

CNBC TV18

Jubilant Pharmova's subsidiary to acquire 80% stake in Pierre Fabre's R&D centre in France

Shares of Jubilant Pharmova Ltd ended at ₹854.90, down by ₹7.05, or 0.82% on the BSE.

Mint

Rakesh Jhunjhunwala Multibagger stocks- Geojit, NCC are among 4 key stocks having returned up to 123% over last year

Rakesh Jhunjhunwala Stocks: Geojit Financial Services, Raghav Productivity Enhancers Ltd, Jubilant Pharmova , NCC Ltd are the stocks in the Rakesh Jhunjhunwala and Associates Portfolio that have given Multibagger returns during last one year. Check details change in shareholdings.

Mint

Jubilant FoodWorks stock zooms 9% to hit 31-month high on solid Q1 numbers; is it time to buy?

Jubilant FoodWorks' Q1 FY2025 showed a 9.9% revenue growth to ₹1,440 crore, though EBITDA margins fell. Domino’s India reported 3% LFL growth and saw record-high app usage. The company plans to add 180 Domino’s stores and 20–25 Hong’s Kitchen stores in India.

Business Standard

Jagran Prakashan Q1 result: PAT dips 6.5% to Rs 41 cr, revenue at Rs 444 cr

Jagran Prakashan Ltd, the publisher of Hindi daily Dainik Jagran, on Saturday reported a decline of 6.51 per cent in its consolidated net profit at Rs 41.03 crore in the first quarter ended June 2024. The company had posted a net profit of Rs 43.89 crore in the April-June quarter a year ago, according to a regulatory filing from Jagran Prakashan Ltd (JPL). Its revenue from operations was down 2.3 per cent to Rs 444.11 crore in the June quarter. It was at Rs 454.57 crore in the corresponding quarter a year ago. JPL's total expenses declined 2.28 per cent to Rs 409.82 crore in the June quarter of FY25. Its revenue from printing, publishing and digital was at Rs 303.54 crore, down 8 per cent year on year. Revenue from FM radio business was up 12.41 per cent to Rs 59.60 crore during the reporting quarter. Total income of JPL, which includes other income, was down 1.88 per cent year on year to Rs 467.23 crore.

Business Standard

Ireda Q1FY25 results: Net profit surges over 30% to Rs 383.69 crore

Indian Renewable Energy Development Agency (Ireda) on Friday reported over 30 per cent growth in its net profit to Rs 383.69 crore for the June quarter, mainly on the back of higher revenues. "IREDA has achieved Profit After Tax of Rs 383.69 crore (in Q1), marking an impressive year-on-year growth of 30.25 per cent," a company statement said. According to the statement, its net profit was Rs 294.58 crore in the quarter ended on June 30, 2023. As the largest pure-play green financing NBFC in the country, it stated that Ireda achieved a new industry standard by publishing its audited financial results within only 12 days. This milestone also marks Ireda as the first central public sector enterprise (CPSE) to promptly declare results and achieve the fastest publication of audited results in the banking and NBFC space, it added. The company has successfully reduced its net non-performing assets to 0.95 per cent in the first quarter of FY 2024-25 from 1.61 per cent in the same quarter

Business Standard

Volumes soar at Jubilant Ingrevia Ltd counter

Jubilant Ingrevia Ltd clocked volume of 85.85 lakh shares by 14:14 IST on NSE, a 37.32 times surge over two-week average daily volume of 2.30 lakh shares

The Economic Times

Indians like to have a swig of premium beer

Premium beers significantly outpaced the overall beer market in FY24, with a 25-30% volume growth compared to the 8-10% growth of the beer category. Bira91's Taproom pubs in Ludhiana are finding success with flavored premium beers, challenging stereotypes in Punjab. Companies like United Breweries and AB InBev are capitalizing on the trend, with the Indian beer market projected to reach Rs 62,240 crore by 2028, driven by premiumization and changing consumer preferences.

Mint

Nifty 50 July series: From Vedanta to Biocon—4 stocks where investors can park their money; Do you own?

Vedanta, Biocon, United Breweries Ltd (UBL), and Indus Tower are the top picks for the June series, according to Religare Broking. Here's why the brokerage sees the stocks outperforming this month.

The Economic Times

Jubilant Pharmova's US arm prepays Rs 626 crore term loan

Jubilant Pharmova's US subsidiary secured a $75 million term loan, as of March 31, 2024, the company's gross debt stood at Rs. 3,414 crore and net debt at Rs. 2,457 crore. In FY24, the company reported revenue of Rs. 6,772 crore and a net profit of Rs. 195 crore. The net debt to Ebitda ratio improved from 2.93x to 2.48x.